ACELYRIN, INC.
Biotechnology ResearchCalifornia, United States11-50 Employees
ACELYRIN, INC. is now a part of Alumis. Learn more and follow Alumis here. https://www.linkedin.com/company/alumis-co/posts/?feedView=all
Insights
Innovative Research Focus ACELYRIN, INC. operates within the biotechnology research industry, focusing on developing next-generation immunotherapies for immune-mediated diseases, suggesting a strong potential for collaborations or supply of specialized biotech tools and services.
Clinical Development Stage The company is actively progressing through Phase 2 and Phase 3 clinical trials for its drug candidates like ESK-001 and envudeucitinib, indicating opportunities to support trial management, data analytics, and clinical supply chain solutions.
Strategic Partnerships Partnerships with companies like Kaken in Japan demonstrate a global growth strategy, opening doors for regional distributors, regulatory consultancies, and medical marketing services.
Strong Financial Position With a revenue range of 10 to 25 million dollars and substantial funding of 300 million dollars, ACELYRIN presents potential for enterprise-level collaborations in research, development, and commercialization efforts.
Market Engagement & Events Active participation in leading dermatology and neurology conferences such as AAD and ACTRIMS indicates a focus on research dissemination and partnership development, creating opportunities for educational collaborations and medtech licensing.
Similar companies to ACELYRIN, INC.
ACELYRIN, INC. Tech Stack
ACELYRIN, INC. uses 8 technology products and services including LinkedIn Recruiter, Fastly, SQL, and more. Explore ACELYRIN, INC.'s tech stack below.
- LinkedIn RecruiterApplicant Tracking Systems
- FastlyContent Delivery Network
- SQLDatabase
- Font AwesomeFont Scripts
- LinuxProgramming Languages
- Base SASSoftware As A Service
- Google AnalyticsWeb Analytics
- GoDaddyWeb Hosting
Media & News
ACELYRIN, INC.'s Email Address Formats
ACELYRIN, INC. uses at least 2 format(s):
| ACELYRIN, INC. Email Formats | Percentage |
| First.Last@acelyrin.com | 97% |
| First@acelyrin.com | 2% |
| FLast@acelyrin.com | 1% |
| FLast@alumis.com | 99% |
| LastF@alumis.com | 1% |
Frequently Asked Questions
Where is ACELYRIN, INC.'s headquarters located?
ACELYRIN, INC.'s main headquarters is located at 4149 Liberty Canyon Road Calabasas, California 91301 United States. The company has employees across 2 continents, including North AmericaAsia. What is ACELYRIN, INC.'s stock symbol?
ACELYRIN, INC. is a publicly traded company; the company's stock symbol is SLRN. What is ACELYRIN, INC.'s official website and social media links?
ACELYRIN, INC.'s official website is alumis.com and has social profiles on LinkedInCrunchbase.What is ACELYRIN, INC.'s SIC code NAICS code?
ACELYRIN, INC.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does ACELYRIN, INC. have currently?
As of March 2026, ACELYRIN, INC. has approximately 31 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Of Biometrics: B. W.Vice President - Head Of Cmc, External Manufacturing, And Supply Chain: W. Z.Quality Assurance Consultant (audits), Veeva Qms Owner: C. S.. Explore ACELYRIN, INC.'s employee directory with LeadIQ.What industry does ACELYRIN, INC. belong to?
ACELYRIN, INC. operates in the Biotechnology Research industry. What technology does ACELYRIN, INC. use?
ACELYRIN, INC.'s tech stack includes LinkedIn RecruiterFastlySQLFont AwesomeLinuxBase SASGoogle AnalyticsGoDaddy. What is ACELYRIN, INC.'s email format?
ACELYRIN, INC.'s email format typically follows the pattern of First.Last@acelyrin.com. Find more ACELYRIN, INC. email formats with LeadIQ. How much funding has ACELYRIN, INC. raised to date?
As of March 2026, ACELYRIN, INC. has raised $300M in funding. The last funding round occurred on Sep 13, 2022 for $300M.When was ACELYRIN, INC. founded?
ACELYRIN, INC. was founded in 2020.
Company Overview
- Headquarters
- 4149 Liberty Canyon Road Calabasas, California 91301 United States
- Website
- alumis.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- SLRN
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2020
- Employees
- 11-50
Media & News
Funding & Financials
- $300M
ACELYRIN, INC. has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $300M.
- $10M$25M
ACELYRIN, INC.'s revenue is estimated to be in the range of $10M$25M
Funding & Financials
- $300M
ACELYRIN, INC. has raised a total of $300M of funding over 3 rounds. Their latest funding round was raised on Sep 13, 2022 in the amount of $300M.
- $10M$25M
ACELYRIN, INC.'s revenue is estimated to be in the range of $10M$25M
Company Leadership
B. W.Vice President Of Biometrics
W. Z.Vice President - Head Of Cmc, External Manufacturing, And Supply Chain- C. S.Quality Assurance Consultant (audits), Veeva Qms Owner
S. K.Executive Director, Assistant Controller- C. C.Director Of Quality Assurance
Employee Directory
- T. M.Senior Director Translational
- A. R.Senior Director, Medical Affairs
- B. W.Sr. Director, Preclinical Pharmacology
- D. O.Senior Director, It And Cybersecurity
- D. A.Associate Director, Research And Development Quality And Compliance
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
